ADIO, DoH, Hub71 partner for global life science investment in Abu Dhabi

The Abu Dhabi Investment Office (ADIO) and the Department of Health - Abu Dhabi (DoH), the regulator of the health sector in the Emirate of Abu Dhabi, announced the signing of a strategic partnership with Hub71, Abu Dhabi's global tech ecosystem, to attract global venture capital (VC) investment and accelerate the growth of HealthTech and life sciences startups through the emirate's newly launched Health, Endurance, Longevity, and Medicine (HELM) cluster.

- 

Led by the Abu Dhabi Department of Economic Development (ADDED), ADIO and DoH, the HELM cluster was established to be a global hub for biotechnology, MedTech and digital health innovation. The cluster is projected to contribute Dhs94 billion to Abu Dhabi's GDP and create 30,000 new jobs by 2045.

Under the agreement, which was announced on the sidelines of Abu Dhabi Global Health Week (ADGHW), Hub7l will leverage its extensive VC partner network to showcase investment opportunities within the HELM cluster through targeted roadshows, networking engagements and dedicated promotional initiatives. ADIO will complement these efforts by providing attractive co-investment opportunities, tailored business support and streamlined business facilitation services to attract international VC firms to establish and expand their operations within the cluster.

Hub71 will also proactively connect high-potential startups entering the HELM cluster with relevant VCs, allowing startups to benefit from targeted market access. DoH will provide compliance support while optimising regulatory pathways to attract and streamline investment processes in the life sciences sector.